Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Heart rate variations during sleep: A new biomarker of depression?

EF 2017-18

Résumé
Depressive disorders and heart diseases are expected to become two of the leading causes of global burden of disease by 2030. The risk of developing new or worsening cardiovascular disease increases by approximately 80% in adults with depression. In fact, depression is associated with variable and elevated heart rate during sleep, as well as decreased heart rate variability (HRV), which are both risk factors for cardiac illness and mortality. It remains to be investigated whether these patterns of heart rate changes during sleep can be used as objective biomarkers of depression. For the first time, this study will assess the differences in heart rate patterns across different sleep stages in individuals with depression, while also investigating the effects of medication use, comorbid sleep disorders, and depression severity. Secondly, the study will validate an algorithm that uses heart rate changes across sleep-wake transitions in order to distinguish between individuals with depressive disorders and healthy controls. This study will contribute to the understanding of the effects of depression on sleep-stage specific regulation of heart rate, which is clinically relevant to both depressive and cardiovascular disorders. Also, the validation of a heart rate profiling algorithm could unveil a new objective biomarker of depression, which can serve as a relatively non-invasive, and inexpensive additional diagnostic tool for depressive states. The validation of a physiological variable as a biomarker of depression may also clarify some aspects of the interactions between mental and physical health. This could highlight new avenues for more accessible and holistic patient care and may contribute to reducing the stigma of mental illness.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
386348
Name
Saad Mysa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Heart rate variations during sleep: A new biomarker of depression?
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autonomic Nervous System; Biomarker; Cardiovascular; Depression; Sleep
Abstract
Depressive disorders and heart diseases are expected to become two of the leading causes of global burden of disease by 2030. The risk of developing new or worsening cardiovascular disease increases by approximately 80% in adults with depression. In fact, depression is associated with variable and elevated heart rate during sleep, as well as decreased heart rate variability (HRV), which are both risk factors for cardiac illness and mortality. It remains to be investigated whether these patterns of heart rate changes during sleep can be used as objective biomarkers of depression. For the first time, this study will assess the differences in heart rate patterns across different sleep stages in individuals with depression, while also investigating the effects of medication use, comorbid sleep disorders, and depression severity. Secondly, the study will validate an algorithm that uses heart rate changes across sleep-wake transitions in order to distinguish between individuals with depressive disorders and healthy controls. This study will contribute to the understanding of the effects of depression on sleep-stage specific regulation of heart rate, which is clinically relevant to both depressive and cardiovascular disorders. Also, the validation of a heart rate profiling algorithm could unveil a new objective biomarker of depression, which can serve as a relatively non-invasive, and inexpensive additional diagnostic tool for depressive states. The validation of a physiological variable as a biomarker of depression may also clarify some aspects of the interactions between mental and physical health. This could highlight new avenues for more accessible and holistic patient care and may contribute to reducing the stigma of mental illness.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Saad, Mysa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~